Lapatinib and Obatoclax Kill Breast Cancer Cells through Reactive Oxygen Species-Dependent Endoplasmic Reticulum Stress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lapatinib and Obatoclax Kill Breast Cancer Cells through Reactive Oxygen Species-Dependent Endoplasmic Reticulum Stress

Published:2012-09-18 Issue:6 Volume:82 Page:1217-1229
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Cruickshanks Nichola,Tang Yong,Booth Laurence,Hamed Hossein,Grant Steven,Dent Paul

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Autophagy in human tumors: cell survival or death?

2. Autophagy can contribute to cell death when combining targeted therapy;Amaravadi;Cancer Biol Ther,2009

3. Treatment of HER2-positive breast cancer: current status and future perspectives

4. Lapatinib ditosylate: expanding therapeutic options for receptor tyrosine-protein kinase erbB-2-positive breast cancer;Awada;Drugs Today (Barc),2011

5. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer;Cancer Cell International;2024-07-09

2. Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures;Neuro-Oncology Advances;2023-01-01

3. ER stress as a trigger of UPR and ER-phagy in cancer growth and spread;Frontiers in Oncology;2022-11-03

4. Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway;Acta Biochimica et Biophysica Sinica;2022-07-01

5. Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells;Cancers;2022-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3